BioSpace News Archive

Ambra Health, makers of the leading cloud-based, medical image management suite, announced a virtual meeting series highlighting presentations that were previously scheduled at HIMSS.

New York Magazine recently asked nearly 50 physicians, nurses, and pharmacists for their recommended medicine cabinet essentials, including thermometers.

Feinstein Institutes for Medical Research and North Shore University Hospital pioneer video recording and review process to improve live-saving CPR process

We are in the midst of a health crisis with a growing number of confirmed cases of COVID-19 here in the US. It is affecting millions of people around the world and the numbers increase daily. China, Japan, South Korea, Italy, France, Germany, Iran, and others are taking emergency actions to prevent the disease from spreading further.

HealthCare.com today released a study conducted to gauge American’s fears about the personal and financial risks of COVID-19, also known as the coronavirus.

As the world comes together to fight coronavirus, Canadians with life-threatening rare and common diseases are marching on Parliament Hill to ask for the same support in the Fight for Our Lives.

Researchers observed male and female soccer players during competitive play and found that head impact sensor data requires video to review false positives

Quantzig, a global data analytics and advisory firm, that delivers actionable analytics solutions to resolve complex business problems has announced the completion of its recent engagement during the course of which they helped a leading player in the precision medicine market to drive better outcomes using pharmacovigilance analytics.

FibroGenesis, a Texas-based regenerative medicine company focused on tissue regeneration and chronic disease reversal using Human Dermal Fibroblasts (HDFs), today announced the filing of United States Provisional Patent Number 62/986,339 titled, “Fibroblast and TLR Activated Fibroblast Treatment of Viral Induced Acute Respiratory Distress Syndrome.”

Agency Continues to Conduct Inspections to Ensure Compliance with Focus on Targeted Unauthorized Flavored E-Cigarette Products Appealing to Youth